Press Releases from DelveInsight Business Research LLP (2368 total)
Non-Alcoholic Fatty Liver Disease (NAFLD) Pipeline Analysis (2023) Covering Clin …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 110+ key pharma and biotech companies are working on 160+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease (NAFLD) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Non-Alcoholic Fatty Liver…
Lung Adenocarcinoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Lung Adenocarcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Lung Adenocarcinoma Pipeline Insight, 2023" report…
Glomerulonephritis Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Glomerulonephritis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Glomerulonephritis Pipeline Insight, 2023" report by DelveInsight provides…
HER2 Negative Metastatic Breast Cancer Pipeline Analysis (2023) Covering Clinica …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the HER2 Negative Metastatic Breast Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"HER2 Negative Metastatic…
Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis (2023) Covering Clinical Tr …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 135+ key pharma and biotech companies are working on 150+ pipeline drugs in the Non-Small Cell Lung Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Non-Small Cell Lung Cancer…
Hypertension Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapi …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 100+ pipeline drugs in the Hypertension therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Hypertension Pipeline Insight, 2023" report by DelveInsight…
Myositis Pipeline, FDA Approvals, Clinical Trials Developments and Companies 202 …
DelveInsight's, "Myositis Pipeline Insight 2023," report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myositis pipeline landscape. It covers the Myositis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myositis Pipeline Report
• DelveInsight's Myositis pipeline report…
Constipation Pipeline, FDA Approvals, Clinical Trials Developments and Companies …
DelveInsight's, "Constipation Pipeline Insight 2023" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers the Constipation pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Constipation pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Constipation Pipeline Report
• DelveInsight's Constipation…
Alpha-1 Antitrypsin Deficiency Pipeline, FDA Approvals, Clinical Trials Developm …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2023" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers the Alpha-1 Antitrypsin Deficiency pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alpha-1 Antitrypsin Deficiency pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Cirrhosis Pipeline, FDA Approvals, Clinical Trials Developments and Companies 20 …
DelveInsight's, "Cirrhosis Pipeline Insight, 2023," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Cirrhosis pipeline landscape. It covers the Cirrhosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Cirrhosis Pipeline Report
• DelveInsight's Cirrhosis pipeline report…
Crohn's Disease Pipeline, FDA Approvals, Clinical Trials Developments and Compan …
DelveInsight's, "Crohn's Disease Pipeline Insight, 2023," report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the Crohn's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Crohn's…
Post-Polycythemia Vera Myelofibrosis Pipeline Analysis (2023) Covering Clinical …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 17+ key pharma and biotech companies are working on 17+ pipeline drugs in the Post-Polycythemia Vera Myelofibrosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Post-Polycythemia Vera Myelofibrosis Pipeline Insight,…
Overactive Bladder Pipeline Analysis (2023) Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Overactive Bladder therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Overactive Bladder Pipeline Insight, 2023" report…
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Pipeline Analysis (2023) Cover …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 13+ key pharma and biotech companies are working on 13+ pipeline drugs in the Chemotherapy-Induced Peripheral Neuropathy (CIPN) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Chemotherapy-Induced Peripheral Neuropathy (CIPN)…
Synovial Sarcoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging The …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 14+ key pharma and biotech companies are working on 14+ pipeline drugs in the Synovial Sarcoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Synovial Sarcoma Pipeline Insight, 2023" report…
Chronic Hepatitis B Virus Pipeline Analysis (2023) Covering Clinical Trials, Eme …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Chronic Hepatitis B Virus therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Chronic Hepatitis B Virus…
Atopic Dermatitis Pipeline, FDA Approvals, Clinical Trials Developments and Comp …
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2023" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Atopic Dermatitis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Guillain-Barre Syndrome Pipeline Analysis (2023) Covering Clinical Trials, Emerg …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Guillain-Barre Syndrome (GBS) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Guillain-Barre Syndrome (GBS) Pipeline Insight, 2023"…
Relapsed Or Refractory Myelodysplastic Syndrome Pipeline Analysis (2023) Coverin …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Relapsed Or Refractory Myelodysplastic Syndrome therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Relapsed Or Refractory Myelodysplastic…
Candidemia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Candidemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Candidemia Pipeline Insight, 2023" report by DelveInsight provides…
Metastatic Urothelial Carcinoma Pipeline Analysis (2023) Covering Clinical Trial …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Metastatic Urothelial Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Metastatic Urothelial Carcinoma Pipeline Insight,…
Pediatric Brain Tumors Pipeline Analysis (2023) Covering Clinical Trials, Emergi …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 7+ key pharma and biotech companies are working on 7+ pipeline drugs in the Pediatric Brain Tumors therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Pediatric Brain Tumors Pipeline Insight,…
Atrial Flutter Market to Witness Growth by 2032 | Acutus Medical, ARCA Biopharma …
DelveInsight's "Atrial Flutter Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atrial Flutter, historical and forecasted epidemiology as well as the Atrial Flutter market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Atrial Flutter market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Atrial Flutter market size…
Encephalitis Market to Witness Growth by 2032 | Merck, Pfizer, GlaxoSmithKline, …
DelveInsight's "Encephalitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Encephalitis, historical and forecasted epidemiology as well as the Encephalitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Encephalitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Encephalitis market size from 2019 to 2032, segmented…
Autism Spectrum Disorder Market | Scioto Biosciences, ACADIA Pharmaceuticals Inc …
DelveInsight's "Autism Spectrum Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autism Spectrum Disorder, historical and forecasted epidemiology as well as the Autism Spectrum Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autism Spectrum Disorder market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Atypical Teratoid Rhabdoid Tumors Market to Witness Growth by 2032 | Epizyme, Ta …
DelveInsight's "Atypical Teratoid Rhabdoid Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atypical Teratoid Rhabdoid Tumors, historical and forecasted epidemiology as well as the Atypical Teratoid Rhabdoid Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Atypical Teratoid Rhabdoid Tumors market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Gastritis Market to Witness Growth by 2032 | Marinomed Biotech AG, an …
DelveInsight's "Autoimmune Gastritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Gastritis, historical and forecasted epidemiology as well as the Autoimmune Gastritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Gastritis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Autoimmune Gastritis market size…
Rheumatoid Arthritis Pipeline, FDA Approvals, Clinical Trials Developments and C …
DelveInsight's, "Rheumatoid Arthritis Pipeline Insight 2023" report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in the Rheumatoid Arthritis pipeline landscape. It covers the Rheumatoid Arthritis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Rheumatoid Arthritis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Acute Ischemic Stroke Pipeline, FDA Approvals, Clinical Trials Developments and …
DelveInsight's, "Acute Ischemic Stroke Pipeline Insight 2023" report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in the Acute Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Acute Ischemic Stroke pipeline products in this space.
Key takeaways from the Acute…
Huntington's Disease Pipeline, FDA Approvals, Clinical Trials Development and Co …
DelveInsight's, "Huntington's Disease Pipeline Insight 2023" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Huntington's Disease pipeline landscape. It covers the Huntington's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Huntington's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Huntington's…
Bipolar Disorder Pipeline, FDA Approvals, Clinical Trials Developments and Compa …
DelveInsight's, "Bipolar Disorder Pipeline Insight 2023" report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bipolar Disorder Pipeline…
Niemann-Pick-Disease Pipeline, FDA Approvals, Clinical Trials Development and Co …
DelveInsight's, "Niemann-Pick-Disease Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Niemann-Pick-Disease pipeline landscape. It covers the Niemann-Pick-Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Niemann-Pick-Disease Pipeline Report
• DelveInsight's Niemann-Pick-Disease pipeline report…
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Pipeline Analysis Covering Cli …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the MALT Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"MALT Lymphoma Pipeline Insight, 2023" report…
Hodgkin's Lymphoma Pipeline Analysis Covering Clinical Trials, Emerging Therapie …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Hodgkin's Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Hodgkin's Lymphoma Pipeline Insight, 2023" report…
Mantle Cell Lymphoma Pipeline Analysis Covering Clinical Trials, Emerging Therap …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Mantle Cell Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Mantle Cell Lymphoma Pipeline Insight,…
Multiple Myeloma Pipeline Analysis Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 130+ pipeline drugs in the Multiple Myeloma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Multiple Myeloma Pipeline Insight, 2023" report…
Diffuse Large B-cell Lymphoma (DLBCL) Pipeline Analysis Covering Clinical Trials …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Renal Cell Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Diffuse Large B-cell Lymphoma Pipeline…
Atopic Dermatitis Market to Witness Growth by 2032 | Amgen, Kyowa Kirin, Dermira …
DelveInsight's "Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atopic Dermatitis, historical and forecasted epidemiology as well as the Atopic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Atopic Dermatitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Atopic Dermatitis market size…
Adult T-cell Leukemia-Lymphoma Market to Witness Growth by 2032 | Novartis AG. M …
DelveInsight's "Adult T-cell Leukemia-Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adult T-cell Leukemia-Lymphoma, historical and forecasted epidemiology as well as the Adult T-cell Leukemia-Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adult T-cell Leukemia-Lymphoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Adult-onset Growth Hormone Deficiency Market to Witness Growth by 2032 | Novo No …
DelveInsight's "Adult-onset Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adult-onset Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Adult-onset Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adult-onset Growth Hormone Deficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Ataxia Telangiectasia Market to Witness Growth by 2032 | Matrix Biomed, IntraBio …
DelveInsight's "Ataxia Telangiectasia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ataxia Telangiectasia, historical and forecasted epidemiology as well as the Ataxia Telangiectasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Ataxia Telangiectasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Ataxia Telangiectasia market size…
Atherosclerosis Market to Witness Growth by 2032 | Regeneron, Sanofi, Immunitor, …
DelveInsight's "Atherosclerosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atherosclerosis, historical and forecasted epidemiology as well as the Atherosclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Atherosclerosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Atherosclerosis market size from 2019 to 2032, segmented…
Type 1 Diabetes Pipeline, FDA Approvals, Clinical Trials Developments and Compan …
DelveInsight's, "Type 1 Diabetes Pipeline Insight 2023" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Type 1 Diabetes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Cutaneous T-cell lymphoma Pipeline, FDA Approvals, Clinical Trials Developments …
DelveInsight's, "Cutaneous T-Cell Lymphoma Pipeline Insight 2023" report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in the Cutaneous T-Cell Lymphoma pipeline landscape. It covers the Cutaneous T-cell lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cutaneous T-cell lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Developments, and Co …
DelveInsight's, "Multiple Sclerosis Pipeline Insight 2023" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Metachromatic Leukodystrophy Pipeline, FDA Approvals, Clinical Trials Developmen …
DelveInsight's, "Metachromatic Leukodystrophy Pipeline Insight 2023" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in the Metachromatic Leukodystrophy pipeline landscape. It covers the Metachromatic Leukodystrophy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metachromatic Leukodystrophy therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Metachromatic…
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments and …
DelveInsight's, "Chronic Kidney Disease Pipeline Insights 2023" report provides comprehensive insights about 76+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Kidney Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Age-related Macular Degeneration (AMD) Pipeline Analysis (2023) Covering Clinica …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively working on various pipeline therapies in the Age-related Macular Degeneration therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Age-related Macular Degeneration (AMD) Pipeline…
Cryptococcal Meningitis Pipeline Analysis (2023) Covering Clinical Trials, Emerg …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Cryptococcal Meningitis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Cryptococcal Meningitis Pipeline Insight, 2023" report…
Chemotherapy Induced Anemia Pipeline Analysis (2023) Covering Clinical Trials, E …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively developing novel therapies in the Chemotherapy Induced Anemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Chemotherapy Induced Anemia Pipeline Insight, 2023" report…
